Submission + - Large Detroit study finds that Hydroxychloroquine lowers COVID-19 death rate (detroitnews.com)
ilguido writes: A study by the Henry Ford Health System shows the anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients. Steven Kalkanis, CEO of the Henry Ford Medical Group, commented: "the data here is clear that there was a benefit to using the drug as a treatment for sick, hospitalized patients". The Detroit News reports that "many health care institutions, including the World Health Organization, suspended clinical trials of the drug touted by President Donald Trump after the faulty study was published in the British medical journal The Lancet on May 22". However "the WHO restarted the trials in June".
The paper has been published on the International Journal of Infectious Diseases: https://ancillary-proxy.atarimworker.io?url=https%3A%2F%2Fwww.ijidonline.com%2Fart...
The paper has been published on the International Journal of Infectious Diseases: https://ancillary-proxy.atarimworker.io?url=https%3A%2F%2Fwww.ijidonline.com%2Fart...